A multi-center clinical study of a novel disc-like left atrial appendage closure system: the periprocedural and mid-term outcomes
李双,朱梦云,葛均波,周达新,张晓春,王建安,樊友启,王琰,常栋,陈义汉,陈发东,付华,胡宏德,蔡衡,张玉顺,周箐,马为,霍勇,任重远,赵冬冬,唐恺,赵逸凡,常晓鑫,刘伟静,陈维,徐亚伟
DOI: https://doi.org/10.3760/cma.j.cn.113859-20200609-00134
2020-01-01
Abstract:Objective:This study was designed to evaluate the efficacy and safety of the LEFTEAR closure system for left atrial appendage closure (LAAC) in patients with non-valvular atrial fibrillation (AF) who had contraindications of long-term oral anticoagulation or still high risks of stroke with anticoagulation treatment.Methods:A total of 200 patients with AF underwent LAAC were prospectively recruited in 9 centers nationwide, between April 2014 and March 2019. The enrolled cases had 38-89 (mean 68.3±8.71) years old. There were 112 males (56%) . CHA
2DS
2-VASc scores were (3.5±1.44) points, and HAS-BLED scores (2.5±1.18) points. LAAC was conducted with a novel disc-like closure device, LEFTEAR. Successful closure of LAA was defined as there was no or a small amount of residual shunt (PDL≤3 mm) , evaluated by transesophageal echocardiography (TEE) . The composite end-point events (hemorrhagic/ischemic stroke, systemic embolism, cardiogenic/unexplained death) within 12 months after the procedure were the main efficacy indicators. Severe adverse events (SAE) within 12 months were safety indicators.
Results:Total 196 were implanted with an occluder, and the remaining 4 were not (1 case found with an large LAA which the ostium was great than 35 mm above the upper limit of the clinical program, 1 case gave up after failed attempt of LAAC procedure, 2 cases showed "pericardial tamponade" after AF ablation and no attempt was made to continue LAAC) . Among them, the "hybrid procedures" (LAAC+AF ablation) reached up to 133 cases (66.5%) . Up to December 31, 2019, the mean follow-up was 6 (4, 11) months. There were none major composite endpoint events occurred during the perioperative and follow-up periods. SAE were recorded in 10 cases, of which 7 cases were "pericardial tamponade" , and 3 cases of "occluder detachment or displacement" . All SAE occurred in "hybrid procedures" cases, of which 9 cases occurred in the perioperative period (90%) . Six cases of "pericardial tamponade" were recorded in the perioperative period, and only 2 cases required emergency surgery. The successful rate of immediate LAAC was 100%, among which 178 cases (90.8%, 178/196) had no residual shunt. A total of 153 cases (79.7%, 153/192) had completed at least one follow-up TEE examination, and the successful LAAC rate was 98.7% (151/153 cases) , with no events of device-related thrombosis.Conclusions:LAAC with a novel disc-like occlude, named LEFTEAR, was generally effective and safe. The "hybrid procedures" increased the incidence of adverse events to some extent. This study was the first-in-human study of LEFTEAR, thus further larger sample studies are still needed to verify.